Literature DB >> 2496857

Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.

W Y Craig1, G E Palomaki, J E Haddow.   

Abstract

To examine the association between cigarette smoking in adults and serum lipid and lipoprotein concentrations the results of 54 published studies were analysed. Overall, smokers had significantly higher serum concentrations of cholesterol (3.0%), triglycerides (9.1%), very low density lipoprotein cholesterol (10.4%), and low density lipoprotein cholesterol (1.7%) and lower serum concentrations of high density lipoprotein cholesterol (-5.7%) and apolipoprotein AI (-4.2%) compared with nonsmokers. Among non-smokers and light, moderate, and heavy smokers a significant dose response effect was present for cholesterol (0, 1.8, 4.3, and 4.5% respectively), triglycerides (0, 10.7, 11.5, and 18.0%), very low density lipoprotein cholesterol (0, 7.2, 44.4, and 39.0%), low density lipoprotein cholesterol (0, -1.1, 1.4, and 11.0%), high density lipoprotein cholesterol (0, -4.6, -6.3, and -8.9%), and apolipoprotein AI (0, -3.7 and -5.7% in non-smokers and light and heavy smokers). These dose response effects may provide new evidence for a causal relation between exposure to cigarette smoke and changes in serum lipid and lipoprotein concentrations whether as a direct result of physiological changes or of dietary changes induced by smoking. Adequate prospective data to estimate the excess risk of coronary artery disease existed only for cholesterol concentration. When that information was combined with data from the present study, and given that smokers as a group face an average overall excess risk of coronary artery disease of 70%, it was estimated that the observed increased serum cholesterol concentration in smokers may account for at least 9% of that excess risk. Furthermore, the dose response effect of smoking on serum cholesterol concentration suggests a gradient of increased absolute risk of coronary artery disease between light and heavy smokers.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496857      PMCID: PMC1836079          DOI: 10.1136/bmj.298.6676.784

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  49 in total

1.  Relationships between cigarette smoking, oral contraceptives, and plasma vitamins A, E, C, and plasma triglycerides and cholesterol.

Authors:  D L Yeung
Journal:  Am J Clin Nutr       Date:  1976-11       Impact factor: 7.045

2.  High density lipoproteins (HDL) and physical activity: the influence of physical exercise, age and smoking on HDL-cholesterol and the HDL-/total cholesterol ratio.

Authors:  S C Enger; K Herbjørnsen; J Erikssen; A Fretland
Journal:  Scand J Clin Lab Invest       Date:  1977-05       Impact factor: 1.713

3.  A method for combining results from several prospective epidemiologic studies.

Authors:  A R Dyer
Journal:  Stat Med       Date:  1986 Jul-Aug       Impact factor: 2.373

4.  Biological, psychological, and social characteristics of men with different smoking habits.

Authors:  C D Jenkins; S J Zyzanski; R H Rosenman
Journal:  Health Serv Rep       Date:  1973-11

5.  Serum beta lipoproteins and cholesterol in men. Relationships to smoking, age and body weight.

Authors:  E Boyle; I B Morales; M Z Nichaman; C R Talbert; R S Watkins
Journal:  Geriatrics       Date:  1968-12

6.  Effects of smoking on oral fat tolerance and high density lipoprotein cholesterol.

Authors:  R S Elkeles; S R Khan; V Chowdhury; M B Swallow
Journal:  Clin Sci (Lond)       Date:  1983-12       Impact factor: 6.124

7.  Influence of smoking on the plasma lipoprotein profile.

Authors:  D Seidel; P Cremer; H Elster; M Weise; H Wieland
Journal:  Klin Wochenschr       Date:  1984

8.  Plasma HDL cholesterol and the subclasses HDL2 and HDL3 in smokers and non-smokers.

Authors:  L A Nesje; O D Mjøs
Journal:  Artery       Date:  1985

9.  Effects of cigarette smoking on fasting triglyceride, total cholesterol, and HDL-cholesterol in women.

Authors:  W Willett; C H Hennekens; W Castelli; B Rosner; D Evans; J Taylor; E H Kass
Journal:  Am Heart J       Date:  1983-03       Impact factor: 4.749

10.  Changes in blood lipids and blood pressure during adolescence.

Authors:  T J Orchard; M Rodgers; A J Hedley; J R Mitchell
Journal:  Br Med J       Date:  1980-06-28
View more
  175 in total

1.  Attenuation of the cardiac inflammatory changes and lipid anomalies by (-)-epigallocatechin-gallate in cigarette smoke-exposed rats.

Authors:  A Gokulakrisnan; B Jayachandran Dare; C Thirunavukkarasu
Journal:  Mol Cell Biochem       Date:  2011-06-03       Impact factor: 3.396

2.  Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart.

Authors:  J R Payne; K I Eleftheriou; L E James; E Hawe; J Mann; A Stronge; P Kotwinski; M World; S E Humphries; D J Pennell; H E Montgomery
Journal:  Heart       Date:  2006-06-27       Impact factor: 5.994

3.  Smoking, smoking cessation, and risk of cardiovascular disease.

Authors:  Peter W F Wilson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-08

4.  Healthy lifestyle impact on breast cancer-specific and all-cause mortality.

Authors:  Adaline E Heitz; Richard N Baumgartner; Kathy B Baumgartner; Stephanie D Boone
Journal:  Breast Cancer Res Treat       Date:  2017-08-31       Impact factor: 4.872

Review 5.  Management of the hypertensive patient who smokes.

Authors:  H Pardell; R Tresserras; E Saltó; P Armario; R Hernández
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

6.  Are investments in disease prevention complements? The case of statins and health behaviors.

Authors:  Robert Kaestner; Michael Darden; Darius Lakdawalla
Journal:  J Health Econ       Date:  2014-04-16       Impact factor: 3.883

Review 7.  Comorbidities in chronic obstructive pulmonary disease.

Authors:  Wissam M Chatila; Byron M Thomashow; Omar A Minai; Gerard J Criner; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 8.  The benefits of stopping smoking and the role of nicotine replacement therapy in older patients.

Authors:  S G Gourlay; N L Benowitz
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

Review 9.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

10.  Hyperinsulinaemia, dyslipidaemia and exaggerated adrenal androgen response to adrenocorticotropin in male smokers.

Authors:  A Hautanen; H Adlercreutz
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.